CAR TCR Summit Logo

CAR TCR Therapy
Summit 2019

LEARN. NETWORK. GAIN NEW PERSPECTIVES,
TAKE IT BACK TO YOUR TEAM

October 17-18, 2019 | Rome, Italy

Welcome to the
CAR - TCR Therapy Summit 2019

The recent EMA approval for commercial CAR-T cell products, i.e. Kymriah and Yescarta marked the beginning for the rapidly evolving field of innovative cellular and gene therapies manufactured from haematopoietic tissues.

The mission of our Annual CAR-TCR Therapy Summit is to empower our guests with critical insights into the delivery of next generation CAR & TCR therapies. 

The summit starts with the keynote panel addressing latest regulatory developments, off-the-shelf CAR & commercial ecosystem in Europe. The summit is split into 2 main themes – Novel Cancer Treatment Therapies & Scale-up & Automation.

The first stream provides latest insights into solid tumour targeting, allogeneic therapy development, breakthroughs with gamma delta cells, innovative antigen screening platforms and genetic engineering strategies to accelerate the translation of basic scientific advances into the clinic and integrate academic and commercial aspects into the development of somatic cell therapy and gene therapy.

The second stream is for those who come to learn about automating manufacturing processes to reduce the cost of goods, discuss market access and logistics, regulations and reimbursement, supply chain and partner management programs.

0
Speakers
0 +
Participants
0
Exhibitors
0
Roundtables

Key Elements of
CAR - TCR Therapy Summit 2019

Regulatory Developments

Solid Tumour Targeting

Novel Cancer Treatment Therapies

Allogeneic Therapy Development

Scale-up & Automation

Manufacturing Processes

Breakthroughs with gamma delta cells

Genetic Engineering Strategies

Partner Management Programs

Get the complete program line-up, speaker details,
full event schedule and more.

Who Attends

Job Titles:

CEOs, VPs, Directors and Heads of: 

Advanced Therapy Production
Quality Control
Biotherapeutics
R&D
Business Development
ED Oncology Trial Manager
CAR-T
Pharmacy Technology
Cell Engineering
Precision Medicine
Cell Therapy

Job Titles:

CEOs, VPs, Directors and Heads of: 

Cellular
Scientific Director
Chief Scientific Officer
Senior Bioengineer
Supply Chain
CMC
Tissue Therapy
Translational medicine
Early Development Leader
Tumor Microenvironment
Immunology

Job Titles:

CEOs, VPs, Directors and Heads of: 

Tumor targeting
Immunotherapy
Vice-President
Innovation
VP Clinical Applications
Manufacturing
Immuno-Oncology
Market Access
Molecular Biology
Regulatory Affairs
ED Investigational Product Specialist

Event Program of CAR TCR Therapy Summit

Day 1

8:00 - 9:00 - Registration and Morning Breakfast

9:45 - 10:45

Latest Developments of CAR-TCR in Europe
....

10:45 - 11:30

Automate and De-centralise: A Perspective for CAR
....

11:45 - 12:00 - Networking Break

12:00 - 13:00 - Interactive Discussion Roundtables

Each roundtable has a moderator and lasts 30 minutes. By the end of the first session, you’re offered to switch the tables for a different session.

IDR A: Armored CAR T-cells to enhance anti-tumor efficacy
IDR B: How to run a clinical program
IDR C: How should CMC and Allogeneic vs Autologous: the potential of off-the-shelf therapies
IDR D: TCR vs CAR
IDR E: Cross-Functional Strategy for Success: Regulatory, Market access & Commercialisation
IDR F: Solid tumour targeting: overcoming the tumour microenvironment

13:00 – 14:00 - Networking Lunch

14:00 - 16:40

2 Different Streams, each one is filled with 4 case studies

STREAM A - Novel Cancer Treatment Therapies


> TCR-T Cell-based cancer immunotherapy
>Chimeric antigen receptors: driving immunology towards synthetic biology
> Allogeneic CAR-T Cell Therapy: Barriers and Challenges
>Single CAR T cell as a mean of targeting multiple tumor antigens
...

STREAM B - Scale Up & Autoamtion


>Automate Autologous Therapy
>Bringing an Off-the Shelf Therapy Through to Commercialization
>Establishing Scalable Supply & Logistics
>Communication and Collaboration with all partners across the ecosystem
...

17:30- Chairman Closing Remarks and end of day 1

18:00 - Cocktail Reception & Live Music Band

Day 2

8:00 - 9:30 - Registration and Morning Breakfast

9:45 – 10:45

Latest Advances on Market Access Innovations for CAR-T
....

10:45 - 11:30

TALEN-mediated gene-editing: transform cell therapy with allogeneic off-the-shelf CAR-T cells
....

11:30 – 12:00 - Networking Break

12:00 – 13:00 - IDR

Each roundtable has a moderator and lasts 30 minutes. By the end of the first session, you’re offered to switch the tables for a different session.

IDR A: Business Aspects of Engineered T Cell Therapies
IDR B: CAR-T cells domestic distribution and logistics
IDR C: CAR-T toxicity and patients
IDR D: Management of Patients and Caregivers
IDR E: Prospects for Off-the-Shelf CAR Therapy
IDR F: Human vs Mouse Experiments

13:00 – 14:00 - Networking Lunch

14:00 - 16:40

2 Different Streams, each one is filled with 2-3 case studies

STREAM A


>TCR-T Cell-based cancer immunotherapy
>Gamma Delta T cells for the treatment of Cancer
>CD19 & Beyond
...

STREAM B


>Making Reimbursement feasible by cutting down the cost of manufacturing
>CAR-T Cell Manufacturing: Process Development
>A Future Beyond B-cell Malignancies: Improving Access to Autologous Cell Therapy
...

16:30 – Closing Remarks from the Chair

17:00 - Close of Annual CAR-TCR Therapy Summit

Sponsors

Attending Companies

Media Partners

Join us in Beautiful Rome !

Venue to be Announced

Choose the perfect Package

For more information please contact enquiry[@]annolucisevents.com

GOVERNMENT
ACADEMIC
PASS

€1000

  • Access to Speakers' Presentations
  • Access to 2 Days of Conference
  • Access to Participants List
  • Interact, Benchmark & Learn
  • Wind-Down, Cocktail Reception & Networking Activities
  • Beverages & Coffee / Tea Breaks

Delegate Package

€2295

  • Access to Speakers' Presentations
  • Access to 2 Days of Conference
  • Access to Participants List
  • Interact, Benchmark & Learn
  • Wind-Down, Cocktail Reception & Networking Activities
  • Beverages & Coffee / Tea Breaks

Solution
Provider

€3000

  • DELEGATE PACKAGE
  • Banner Placement
  • Participating Company Wish List
  • Access to Participant List 2 Weeks before event
  • One Pre-Arranged 1-1 Meeting
  • Social Media Mentions
  • Networking in LinkedIn Group
  • Post Event Report

How it unfolded at one of our previous summits

What Other Attendees Say

One of the things I really like about this conference is interactions between panelists, speakers and audience. We had so many discussion without any kind of barriers. This conference provides platform for a very open and interactive learning and networking.
Lex Tan
MOTIONSCLOUD
The added value of attending Anno Lucis event here, is that you get an opportunity to interact with a lot of peers, people from different background.
Cees Werff
CLAIMS CORPORATION NETWORK
This conference was very welcoming from the start. People were keen to interact, to speak with each other and to learn more about each other’s background. A great atmosphere was created and I will happily come back to this type of event!
Nick Pester
CAPITAL LAW LLP